← Browse by Condition
Medical Condition

urothelial carcinoma recurrent

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06823427 Phase 2
Recruiting

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

Enrollment
60 pts
Location
China
Sponsor
Mabwell (Shanghai) Bioscience ...
View Trial →